Overview

Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of Epratuzumab with standard treatments for patients with SLE.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Epratuzumab